Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.6B | 1.4B | 1.1B | 1.3B |
Cost of revenue | 911M | 821M | 611M | 696M |
Gross profit | 731M | 614M | 483M | 559M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 100M | 141M | 123M | 132M |
Operating income | 455M | 246M | 151M | 211M |
Non operating interest income | ||||
Income | 48M | 119M | 48M | 77M |
Expense | 63M | 65M | 61M | 68M |
Other income expense | — | — | — | — |
Pretax income | 450M | 388M | 160M | 272M |
Tax provision | 88M | 49M | 27M | 57M |
Net income | 362M | 338M | 133M | 215M |
Basic EPS | 0.4 | 0.4 | 0.1 | 0.2 |
Diluted EPS | 0.4 | 0.4 | 0.1 | 0.2 |
Basic average shares | 897.3M | 897.3M | 897.3M | 904.2M |
Diluted average shares | 897.3M | 897.3M | 897.3M | 904.2M |
EBITDA | 599M | 563M | 331M | 434M |
Net income from continuing op. | 362M | 338M | 133M | 215M |
Minority interests | 1M | 6M | -1M | 2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |